Basic Search
|
Summaries
|
Advanced Search
Violation Tracker Current Parent Company Summary
Current Parent Company Name: Viatris
Ownership Structure: publicly traded (ticker symbol VTRS)
Headquartered in: Pennsylvania
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $1,606,304,337
Number of records: 41
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
| government-contracting-related offenses | $960,447,700 | 27 |
| competition-related offenses | $515,117,984 | 8 |
| consumer-protection-related offenses | $100,250,000 | 2 |
| financial offenses | $30,000,000 | 1 |
| healthcare-related offenses | $250,000 | 1 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
| False Claims Act and related | $960,447,700 | 27 |
| price-fixing or anti-competitive practices | $514,517,984 | 7 |
| consumer protection violation | $100,250,000 | 2 |
| investor protection violation | $30,000,000 | 1 |
| fraud | $600,000 | 1 |
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the
Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links: For a summary of this company's regulatory penalties in more than 50 other countries, see its Violation Tracker Global summary page
here.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found
here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year | Agency | Penalty Amount  |
| Mylan Inc. | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
| Mylan Inc. | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000 |
| Dey Inc. | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
| Mylan N.V. | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $264,000,000 |
| Mylan Pharmaceuticals and UDL Laboratories | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
| Mylan Pharmaceuticals, Inc. | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
| Mylan Laboratories et al. | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
| Mylan Laboratories, Inc. | consumer protection violation | 2000 | FTC | $100,000,000 |
| Mylan Inc. | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $96,525,000 |
| Mylan Inc. | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $65,000,000 |
| Mylan Inc. | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $57,000,000 |
| Mylan N.V. | investor protection violation | 2019 | SEC | $30,000,000 |
| Mylan Laboratories Inc. | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
| Dey, Inc. | False Claims Act and related | 2003 | DOJ_CIVIL | $18,500,000 |
| Mylan Inc. | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $14,377,600 |
| Dey, Inc. | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Dey, Inc. | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
| Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
| Dey L.P. | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
| Dey Inc. | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
| Dey Labs | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
| Dey, Inc. | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
| Dey | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
| Dey Inc. | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
| Dey, Inc. | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
| Mylan Inc. | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
| Dey Inc. | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
| Dey Pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
| Dey, Inc. | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
| Dey, Inc. | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
| Dey, Inc. | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
| Dey, Inc. | False Claims Act and related | 2006 | ID-AG | $1,072,700 |
| Dey Inc. | False Claims Act and related | 2004 | WV-AG | $850,000 |
| Dey, Inc. | False Claims Act and related | 2007 | NV-AG | $670,000 |
| Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | False Claims Act and related | 2012 | ID-AG | $625,000 |
| Dey, Inc. | fraud | 2004 | AR-AG | $600,000 |
| Mylan Specialty L.P. | consumer protection violation | 2013 | OR-AG | $250,000 |
| Mylan Specialty, L.P. | off-label or unapproved promotion of medical products | 2013 | MA-AG | $250,000 |
| Mylan | wage and hour violation | 2014 | private lawsuit-federal | $225,000 |
| Dey LP | False Claims Act and related | 2007 | MT-AG | $198,000 |
| MYLAN TECHNOLOGIES, INC. | workplace safety or health violation | 2021 | OSHA | $13,653 |
